483
Center for Human ReproductionCenter for Human Reproduction – FDA 483, Feb 23, 2016
Record Details
An FDA inspection of the Center for Human Reproduction in Manhasset, NY, identified significant issues with their anonymous oocyte donor program. The firm failed to establish and follow adequate procedures for screening and determining donor eligibility, including proper documentation and updating of donor information. These deficiencies raise concerns about the thoroughness of donor screening for communicable diseases and the accuracy of critical donor eligibility records.
View Company Profile
ID · 73055180-ad4c-4574-8157-0a9aedb18da3
Other documents for Center for Human Reproduction
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.